1376.1 - 70 gene signature (MammaPrint) for use in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit

Page last updated: 15 November 2018

Application Detail

Status

Open

Description of Medical Service

Microarray 70 gene signature expression profiling of breast cancer, performed on either core biopsy or surgically resected formalin fixed paraffin embedded histological specimen, to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit.

Description of Medical Condition

Early stage breast cancer.

Reason for Application

New MBS item

Medical Service Type

Investigative medical service

Previous Application Number

1376

Associated Documentation

Application Form

Application Form (PDF 627 KB)
Application Form (Word 656 KB)

PICO Confirmation

-

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 882 KB)
Public Summary Document (Word 533 KB)

Meetings for this Application

PASC

12 April 2017

ESC

8-9 February 2018

MSAC

28-29 March 2018